Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deccan Health Care has the GF Score of 77, which implies that the company
is
Likely to have average performance.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Deccan Health Care
is
Likely to have average performance.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Deccan Health Care (BOM:542248) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Deccan Health Care GF Score Related Terms
BOM:542248 vs ZTS: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deccan Health Care GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's GF Score distribution charts can be found below:
* The bar in red indicates where Deccan Health Care's GF Score falls into.
Deccan Health Care (BOM:542248) has a GF Score of 77 as of Aug. 07, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Deccan Health Care and its competitors. This is 26% above median its historical median of 61.00. Over the past decade, Deccan Health Care's GF Score has ranged from 22.00 to 84.00.
Is Deccan Health Care's GF Score too high?
Deccan Health Care's current GF Score of 77 is 26% above median its 10-year median of 61.00. Over the past 10 years, this metric has ranged from a low of 22.00 to a high of 84.00. Overall, Deccan Health Care has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's GF Score compare to ZTS?
Deccan Health Care's GF Score of 77 can be compared against companies in the Drug Manufacturers industry. Historically, Deccan Health Care's own GF Score has ranged from 22.00 to 84.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Deccan Health Care and its competitors. Deccan Health Care's current GF Score is 77, which is 26% above median its own 10-year median of 61.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.15, compared to a current price of ₹13.08 — trading 50% below its estimated fair value. The current GF Score is 77, which is 26% above median its 10-year median of 61.00. Deccan Health Care's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current GF Score is 77 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deccan Health Care (BOM:542248) Overvalued in 2026?
Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued.
The current stock price of ₹13.08 is trading 50% below its estimated GF Value™ of ₹26.15.
GuruFocus considers Deccan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:542248:
GF Score: 77 (26% above median its 10-year median of 61.00)
GF Value™: ₹26.15 vs. price of ₹13.08 (50% below fair value)
No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
77GF Score
Get the complete analysis for BOM:542248
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542248 has been successfully added to your 
